Antisense Therapeutics - a purpose driven biotech with global potential
It is estimated that over 300 million people in the world are impacted by rare diseases. In a recent study it was estimated that rare...
Antisense Therapeutics - a purpose driven biotech with global potential
Two leading Australian biotech companies working to solve global unmet needs
Antisense Therapeutics Shares up 40% in a month. Strong Volume in Europe.
Major global trends driving biotech investment in 2021
Antisense shares have increased by 60% after Sarepta results
mRNA and Antisense biotech - attracting the large fund managers and defining 2020
Why ESG investing is accelerating and which companies will benefit in 2021
Broker upgrades Antisense Therapeutics by 470%
Ionis Pharmaceuticals - A force for life
mRNA and RNA biotechnology – “The software of life”
Australian biotech companies becoming global players